Celebrex TV Ads Modified After FDA Says Pharmacia Overstated Efficacy
Executive Summary
Pharmacia modified a Celebrex direct-to-consumer advertising campaign after FDA found that television spots for the product exaggerated the efficacy of the arthritis drug.
You may also be interested in...
FDA Cites Abbott’s Humira Psoriasis Ad: Patient Does Not Exhibit Severe Disease
Warning letter for Humira ad reprises agency interest in clear identification of appropriate patients.
Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules
An FDA "untitled" letter to Pfizer on Celebrex and Bextra is the agency's second recent objection to the company's interpretation of the boundaries of "reminder" ads
Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules
An FDA "untitled" letter to Pfizer on Celebrex and Bextra is the agency's second recent objection to the company's interpretation of the boundaries of "reminder" ads